The landscape of incident disease risk for the biomarker GlycA and its mortality stratification in angiography patients
By
Johannes Kettunen,
Scott C Ritchie,
Olga Anufrieva,
Leo-Pekka Lyytikäinen,
Jussi Hernesniemi,
Pekka J. Karhunen,
Pekka Kuukasjärvi,
Jari Laurikka,
Mika Kähönen,
Terho Lehtimäki,
Aki S Havulinna,
Veikko Salomaa,
Satu Männistö,
Mika Ala-Korpela,
Markus Perola,
Michael Inouye,
Peter Würtz
Posted 12 Mar 2018
bioRxiv DOI: 10.1101/280677
(published DOI: 10.1161/CIRCGEN.118.002234)
Integration of systems-level biomolecular information with electronic health records has led to the discovery of robust blood-based biomarkers predictive of future health and disease. Of recent intense interest is the GlycA biomarker, a complex nuclear magnetic resonance (NMR) spectroscopy signal reflective of acute and chronic inflammation, which predicts long term risk of diverse outcomes including cardiovascular disease, type 2 diabetes, and all-cause mortality. To systematically explore the specificity of the disease burden indicated by GlycA we analysed the risk for 468 common incident hospitalization and mortality outcomes occurring during an 8-year follow-up of 11,861 adults from Finland. Our analyses of GlycA replicated known associations, identified associations with specific cardiovascular disease outcomes, and uncovered new associations with risk of alcoholic liver disease (meta-analysed hazard ratio 2.94 per 1-SD, P=5 10-6), chronic renal failure (HR=2.47, P=3 10-6), glomerular diseases (HR=1.95, P=1 10-6), chronic obstructive pulmonary disease (HR=1.58, P=3 10-5), inflammatory polyarthropathies (HR=1.46, P=4 10-8), and hypertension (HR=1.21, P=5 10-5). We further evaluated GlycA as a biomarker in secondary prevention of 12-year cardiovascular mortality in 900 angiography patients with suspected coronary artery disease. We observed hazard ratios of 4.87 and 5.00 for 12-year mortality in angiography patients in the fourth and fifth quintiles by GlycA levels demonstrating the prognostic potential of GlycA for identification of high mortality-risk individuals. Both GlycA and C-reactive protein had shared as well as independent contributions to mortality hazard, emphasising the importance of chronic inflammation in secondary prevention of cardiovascular disease.
Download data
- Downloaded 448 times
- Download rankings, all-time:
- Site-wide: 55,910
- In epidemiology: 2,387
- Year to date:
- Site-wide: 93,094
- Since beginning of last month:
- Site-wide: 93,094
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!